Department of Surgery (General Thoracic Surgery)

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Lung 54%
3. Adenocarcinoma of Lung 51%
4. Non-Small Cell Lung Carcinoma 49%
5. Neoplasms 47%
6. Neoplasm Staging 43%
7. Survival 33%
8. Segmental Mastectomy 30%
9. Thymoma 23%
10. Neoplasm Metastasis 23%
11. Recurrence 20%
12. Adenocarcinoma 18%
13. Databases 17%
14. Tomography 16%
15. Thymic epithelial tumor 15%
16. Glass 15%
17. Japan 14%
18. Cryosurgery 14%
19. Registries 12%
20. Mutation 11%
21. Adenocarcinoma in Situ 11%
22. Metastasectomy 11%
23. Medical Oncology 11%
24. Lymph Nodes 11%
25. Carcinoid Tumor 10%
26. Thorax 9%
27. Adjuvant Chemotherapy 9%
28. Cancer-Associated Fibroblasts 9%
29. Therapeutics 9%
30. Survival Rate 9%
31. Propensity Score 9%
32. Malignant Mesothelioma 8%
33. Clinical Trials 7%
34. Safety 7%
35. Dissection 7%
36. Mesothelioma 6%
37. Lymph Node Excision 6%
38. Margins of Excision 6%
39. Retrospective Studies 6%
40. Pneumothorax 6%
41. Colorectal Neoplasms 6%
42. Confidence Intervals 6%
43. Lovastatin 6%
44. Multicenter Studies 5%
45. Carcinoma 5%
46. Tumor Microenvironment 5%
47. Needle Biopsy 5%
48. Chest Tubes 5%
49. Pure Red-Cell Aplasia 5%
50. Idiopathic Pulmonary Fibrosis 5%
51. Trachea 5%
52. Myasthenia Gravis 5%
53. Thymectomy 5%
54. Squamous Cell Carcinoma 5%
55. Air 5%
56. Smoking 5%
57. Local Anesthesia 5%